100% (3/3) patients with cervical cancer were HPV DNA assay positive, 100% (3/3) were HPV E6/E7 mRNA testing positive and 100% (3/3) were p16/Ki67 immunocytochemistry positive (Fig. 1). This evidence concerns the gene MKI67 and cervical carcinoma.